title: Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece.
abstract: A case of central venous catheter-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myelogenous leukaemia is reported. The patient was successfully treated with amikacin and piperacillin-tazobactam. The clinical isolate was identified as R. mucosa by 16S rRNA gene sequencing.
authors.forename: G B
authors.initials: GB
authors.lastname: Christakis
authors.forename: S
authors.initials: S
authors.lastname: Perlorentzou
authors.forename: P
authors.initials: P
authors.lastname: Alexaki
authors.forename: A
authors.initials: A
authors.lastname: Megalakaki
authors.affiliation: Department of Biology, School of Medicine, University of Patras, 26500 Rion Patra, Greece.
authors.forename: I K
authors.initials: IK
authors.lastname: Zarkadis
mesh_terms: D000208:Acute Disease; D000328:Adult; D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000209:etiology*; D001483:Base Sequence; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications* / Q000188:drug therapy; D008297:Male; D042082:Methylobacteriaceae / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D008969:Molecular Sequence Data; D009503:Neutropenia / Q000150:complications*; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010802:Phylogeny; D010878:Piperacillin / Q000627:therapeutic use; D000077725:Piperacillin, Tazobactam Drug Combination; D012329:RNA, Bacterial; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D012329:RNA, Bacterial; D012336:RNA, Ribosomal, 16S; D003561:Cytarabine; D000077725:Piperacillin, Tazobactam Drug Combination; D000583:Amikacin; D010397:Penicillanic Acid; D014740:Vidarabine; C024352:fludarabine; D010878:Piperacillin